- Home
- LNTH vs BXSL Comparison
LNTH vs BXSL Comparison
Compare LNTH & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- BXSL
- Stock Information
- Founded
- LNTH 1956
- BXSL 2018
- Country
- LNTH United States
- BXSL United States
- Employees
- LNTH N/A
- BXSL N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BXSL Trusts Except Educational Religious and Charitable
- Sector
- LNTH Health Care
- BXSL Finance
- Exchange
- LNTH Nasdaq
- BXSL Nasdaq
- Market Cap
- LNTH 7.5B
- BXSL 7.5B
- IPO Year
- LNTH 2015
- BXSL N/A
- Fundamental
- Price
- LNTH $78.95
- BXSL $31.12
- Analyst Decision
- LNTH Strong Buy
- BXSL Buy
- Analyst Count
- LNTH 5
- BXSL 6
- Target Price
- LNTH $133.80
- BXSL $31.38
- AVG Volume (30 Days)
- LNTH 1.3M
- BXSL 1.0M
- Earning Date
- LNTH 05-07-2025
- BXSL 05-07-2025
- Dividend Yield
- LNTH N/A
- BXSL 9.89%
- EPS Growth
- LNTH N/A
- BXSL N/A
- EPS
- LNTH 3.53
- BXSL 3.14
- Revenue
- LNTH $1,536,699,000.00
- BXSL $1,380,706,000.00
- Revenue This Year
- LNTH $5.81
- BXSL $13.05
- Revenue Next Year
- LNTH $12.26
- BXSL $7.20
- P/E Ratio
- LNTH $22.69
- BXSL $9.92
- Revenue Growth
- LNTH 12.53
- BXSL 16.76
- 52 Week Low
- LNTH $74.34
- BXSL $25.89
- 52 Week High
- LNTH $126.89
- BXSL $34.64
- Technical
- Relative Strength Index (RSI)
- LNTH 27.93
- BXSL 61.05
- Support Level
- LNTH $78.61
- BXSL $29.07
- Resistance Level
- LNTH $83.60
- BXSL $30.04
- Average True Range (ATR)
- LNTH 3.87
- BXSL 0.52
- MACD
- LNTH -3.13
- BXSL 0.30
- Stochastic Oscillator
- LNTH 1.12
- BXSL 96.07
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.